9 research outputs found
Fingolimod induces neuroprotective factors in human astrocytes.
Background
Fingolimod (FTY720) is the first sphingosine-1-phosphate (S1P) receptor modulator approved for the treatment of multiple sclerosis. The phosphorylated active metabolite FTY720-phosphate (FTY-P) interferes with lymphocyte trafficking. In addition, it accumulates in the CNS and reduces brain atrophy in multiple sclerosis (MS), and neuroprotective effects are hypothesized.
Methods
Human primary astrocytes as well as human astrocytoma cells were stimulated with FTY-P or S1P. We analyzed gene expression by a genome-wide microarray and validated induced candidate genes by quantitative PCR (qPCR) and ELISA. To identify the S1P-receptor subtypes involved, we applied a membrane-impermeable S1P analog (dihydro-S1P), receptor subtype specific agonists and antagonists, as well as RNAi silencing.
Results
FTY-P induced leukemia inhibitory factor (LIF), interleukin 11 (IL11), and heparin-binding EGF-like growth factor (HBEGF) mRNA, as well as secretion of LIF and IL11 protein. In order to mimic an inflammatory milieu as observed in active MS lesions, we combined FTY-P application with tumor necrosis factor (TNF). In the presence of this key inflammatory cytokine, FTY-P synergistically induced LIF, HBEGF, and IL11 mRNA, as well as secretion of LIF and IL11 protein. TNF itself induced inflammatory, B-cell promoting, and antiviral factors (CXCL10, BAFF, MX1, and OAS2). Their induction was blocked by FTY-P. After continuous exposure of cells to FTY-P or S1P for up to 7 days, the extent of induction of neurotrophic factors and the suppression of TNF-induced inflammatory genes declined but was still detectable. The induction of neurotrophic factors was mediated via surface S1P receptors 1 (S1PR1) and 3 (S1PR3).
Conclusions
We identified effects of FTY-P on astrocytes, namely induction of neurotrophic mediators (LIF, HBEGF, and IL11) and inhibition of TNF-induced inflammatory genes (CXCL10, BAFF, MX1, and OAS2). This supports the view that a part of the effects of fingolimod may be mediated via astrocytes
Additional file 4: Figure S2. of Fingolimod induces neuroprotective factors in human astrocytes
Expression of LIFR, EGFR, and IL11RA on human fetal neural progenitor cells. Fetal Striatal brain cells were differentiated for 7 days (hstrNPCs) and analyzed by qPCR. For comparison, human primary astrocytes (HA) are shown (mean ± SD of two technical replicates)
Additional file 1: Figure S1. of Fingolimod induces neuroprotective factors in human astrocytes
Validation of different house-keeping genes for quantitative PCR in human astrocytes or U373 astrocytoma cells. Human astrocytes (A) or human U373 astrocytoma cells (B, C) were stimulated with the indicated amounts of FTY-P or S1P, followed by stimulation with TNF, when indicated. Eight hours later, cell lysates were harvested and expression of the housekeeping genes GAPDH, beta-actin, and PPIA (cyclophilin) was determined by quantitative PCR (mean ± SEM of two (A) and three (B, C) independent biological replicates)
Additional file 3: Table S2. of Fingolimod induces neuroprotective factors in human astrocytes
Human primary astrocytes, stimulated with FTY-P (left) or S1P (right) for 1 or 8 h and analyzed on an Illumina microarray. Shown are genes with significant regulation with at least one of the compounds (adjusted p value < 0.05, in bold print) at 1 h (upper table) and 8 h (lower table). The list is sorted for fold-changes by FTY-P
La Petite presse : journal quotidien... / [rédacteur en chef : Balathier Bragelonne]
11 juin 18811881/06/11 (A15,N5513)